Thai flu vaccine guidance: focus on safety, not fear of ingredients
A U.S. federal advisory panel advising the CDC recommended that flu vaccines in the United States be available in single-dose, thimerosal-free formats. If adopted, this would standardize vaccines and address public concerns about ingredients. The issue holds global relevance for Thailand’s immunization programs and public confidence in vaccination.
Thimerosal has long sparked debate over mercury exposure and vaccine safety. The advisory panel, refreshed under new leadership, placed the question of thimerosal at the forefront of its agenda. The move reflects public demand for clearer policies rather than evidence of harm and aligns with the FDA’s position that thimerosal has a long history of safe use as a preservative.